<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03438799</url>
  </required_header>
  <id_info>
    <org_study_id>CLN0004</org_study_id>
    <nct_id>NCT03438799</nct_id>
  </id_info>
  <brief_title>A Study to Collect Information for the Cordio System</brief_title>
  <official_title>A Multi-Center Observational Study to Collect Information Related to the Clinical Significance and Performance of the Cordio System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cordio Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cordio Medical</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, observational, non-interventional, prospective, Single-arm, open
      study for database establishment for R&amp;D purposes. R&amp;D data will be analyzed retrospectively
      in order to validate algorithm efficacy.

      The study will be conducted in the following settings: hospital (admission due to CHF
      exacerbation), CHF clinic and at home.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>R&amp;D Database &amp; Efficiency</measure>
    <time_frame>2 years</time_frame>
    <description>Building R&amp;D recording database and retrospectively Cordio System needs to reach correlation between the system generated alerts to HF exacerbation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Usability</measure>
    <time_frame>2 years</time_frame>
    <description>Questionnaires with SUS scale and specific app questions in order to assess the app usability</description>
  </secondary_outcome>
  <other_outcome>
    <measure>SADE Endpoint</measure>
    <time_frame>2 years</time_frame>
    <description>Demonstration of the safe use of the device by overall incidence of device related adverse events.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Cordio</arm_group_label>
    <description>Cordio R&amp;D database to develop the Cordio System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cordio System</intervention_name>
    <description>App, cloud and web device</description>
    <arm_group_label>Cordio</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with NYHA 2-3. All patients must meet eligibility criteria.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 18 years.

          2. Symptomatic Heart Failure Patient.

          3. The patient is willing to participate as evidenced by signing the written informed
             consent.

          4. Male or non-pregnant female patient.

        Exclusion Criteria:

          1. Subject who, in the Investigator's opinion, unable to comply with the daily use of the
             App due to mental disorders (e.g., depression, dementia).

          2. Patient who has had a major cardiovascular event (e.g., myocardial infraction, stroke)
             within 3 months prior to screening visit.

          3. Patient with severe alcohol or drug use.

          4. Psychological instability, inappropriate attitude or motivation.

          5. Patient with life threatening debilitating disease other than cardiac.

          6. Subject currently enrolled in another investigational device or drug trial that has
             not completed the primary endpoint or that clinically interferes with the current
             study endpoints.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Orit Ronen, MSc</last_name>
    <phone>972-3-5467159</phone>
    <email>orit@cordio-med.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clalit Bat Yam</name>
      <address>
        <city>Bat Yam</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Morninkas, Dr.</last_name>
      <phone>058-4753375</phone>
      <email>DANIELMU@clalit.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clalit Be'er Sheva</name>
      <address>
        <city>Be'er Sheva</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Marc Weinstien, Dr.</last_name>
      <phone>052-2707697</phone>
      <email>jmwein@bgu.ac.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clalit Bet Shemesh</name>
      <address>
        <city>Bet Shemesh</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elisha Ouzan, Dr.</last_name>
      <phone>050-7874159</phone>
      <email>elisha_ouzan@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2018</study_first_submitted>
  <study_first_submitted_qc>February 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2018</study_first_posted>
  <last_update_submitted>February 19, 2018</last_update_submitted>
  <last_update_submitted_qc>February 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

